Decreased Brain pH and Pathophysiology in Schizophrenia
- PMID: 34445065
- PMCID: PMC8395078
- DOI: 10.3390/ijms22168358
Decreased Brain pH and Pathophysiology in Schizophrenia
Abstract
Postmortem studies reveal that the brain pH in schizophrenia patients is lower than normal. The exact cause of this low pH is unclear, but increased lactate levels due to abnormal energy metabolism appear to be involved. Schizophrenia patients display distinct changes in mitochondria number, morphology, and function, and such changes promote anaerobic glycolysis, elevating lactate levels. pH can affect neuronal activity as H+ binds to numerous proteins in the nervous system and alters the structure and function of the bound proteins. There is growing evidence of pH change associated with cognition, emotion, and psychotic behaviors. Brain has delicate pH regulatory mechanisms to maintain normal pH in neurons/glia and extracellular fluid, and a change in these mechanisms can affect, or be affected by, neuronal activities associated with schizophrenia. In this review, we discuss the current understanding of the cause and effect of decreased brain pH in schizophrenia based on postmortem human brains, animal models, and cellular studies. The topic includes the factors causing decreased brain pH in schizophrenia, mitochondria dysfunction leading to altered energy metabolism, and pH effects on the pathophysiology of schizophrenia. We also review the acid/base transporters regulating pH in the nervous system and discuss the potential contribution of the major transporters, sodium hydrogen exchangers (NHEs), and sodium-coupled bicarbonate transporters (NCBTs), to schizophrenia.
Keywords: brain pH; dopamine; glutamate; lactate; mitochondria dysfunction; pH-regulating proteins; schizophrenia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- Brisch R., Saniotis A., Wolf R., Bielau H., Bernstein H.G., Steiner J., Bogerts B., Braun K., Jankowski Z., Kumaratilake J., et al. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: Old fashioned, but still in vogue. Front. Psychiatry. 2014;5:47. doi: 10.3389/fpsyt.2014.00047. - DOI - PMC - PubMed
-
- Du F., Cooper A.J., Thida T., Sehovic S., Lukas S.E., Cohen B.M., Zhang X., Ongur D. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. JAMA Psychiatry. 2014;71:19–27. doi: 10.1001/jamapsychiatry.2013.2287. - DOI - PMC - PubMed
-
- Halim N.D., Lipska B.K., Hyde T.M., Deep-Soboslay A., Saylor E.M., Herman M.M., Thakar J., Verma A., Kleinman J.E. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds. J. Neurosci. Methods. 2008;169:208–213. doi: 10.1016/j.jneumeth.2007.11.017. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical